Prices and Related Controversies in the Biopharmaceutical Industry

Richard L Manning

International Journal of the Economics of Business, 2018, vol. 25, issue 1, 157-166

Abstract: This essay reviews selected developments in the economics of the pharmaceutical industry and the public policy issues that arise with respect to the industry. It briefly discusses certain results, provides points of entry into the literature on these key issues, and offers high-level comments about fruitful areas for continuing academic research.

Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1080/13571516.2017.1396008 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:ijecbs:v:25:y:2018:i:1:p:157-166

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/CIJB20

DOI: 10.1080/13571516.2017.1396008

Access Statistics for this article

International Journal of the Economics of Business is currently edited by Eleanor Morgan

More articles in International Journal of the Economics of Business from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().